HAL
53
-2
ZTS
17
5
VMC
59
2
HAS
61
-2
ROK
58
-2
GIS
61
4
MOS
38
-12
LLY
70
5
RRC
63
-2
NEE
54
2
STI
7
-4
ABT
45
4
SLB
46
-3
NKE
48
5
AFL
48
4
MKC
54
4
ISRG
68
5
CRM
50
-9
DVN
43
-5
ETR
55
3
HAL
53
-2
ZTS
17
5
VMC
59
2
HAS
61
-2
ROK
58
-2
GIS
61
4
MOS
38
-12
LLY
70
5
RRC
63
-2
NEE
54
2
STI
7
-4
ABT
45
4
SLB
46
-3
NKE
48
5
AFL
48
4
MKC
54
4
ISRG
68
5
CRM
50
-9
DVN
43
-5
ETR
55
3
Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
35

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$96.65
Seasonality Move:
1.23%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.95
Seasonality Move:
16.15%
Sell
35
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Sell

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $96.83. The Score for TDIV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • TDIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $56.25. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $56.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 45.12 Sell
Chaikin Money Flow: -87217 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.6 - 99.78) Sell
Bollinger Bands (100): (92.55 - 100.05) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 49.63 Sell
Chaikin Money Flow: -869556 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.52 - 56.8) Buy
Bollinger Bands (100): (52.68 - 65.64) Sell

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 99.78 Sell
20-day SMA: 97.16 Sell
50-day SMA: 98.51 Sell
200-day SMA: 88.22 Buy
8-day EMA: 98.88 Sell
20-day EMA: 98.32 Sell
50-day EMA: 95.92 Buy
200-day EMA: 60.26 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.26 Sell
20-day SMA: 54.42 Buy
50-day SMA: 60.38 Sell
200-day SMA: 50.86 Buy
8-day EMA: 56.54 Sell
20-day EMA: 56.01 Buy
50-day EMA: 56.53 Sell
200-day EMA: 36.83 Buy

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):